The Chinese University of Hong Kong
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1963-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cuhk.edu.hk
Retrospective Review on Patients With Culture Negative Empyema
Completed
- Conditions
- Empyema, Pleural
- Interventions
- Other: Disease outcome (mortality)
- First Posted Date
- 2020-07-20
- Last Posted Date
- 2020-07-20
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 153
- Registration Number
- NCT04477980
- Locations
- 🇭🇰
Chinese University of Hong Kong, Hong Kong, Hong Kong
Advanced Translational Research on Childhood Leukemia
Recruiting
- Conditions
- Childhood Leukemia
- Interventions
- Genetic: RNA-seqGenetic: whole exon sequencingOther: Cytogenetics test
- First Posted Date
- 2020-07-20
- Last Posted Date
- 2023-09-25
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 150
- Registration Number
- NCT04478006
- Locations
- 🇨🇳
Hong Kong Children Hospital, Hong Kong, Hksar, China
Oral Nutritional Supplement for the Patient With or at Risk of Malnutrition
Not Applicable
Completed
- Conditions
- Malnutrition
- Interventions
- Dietary Supplement: Fresubin® powder fibre
- First Posted Date
- 2020-07-17
- Last Posted Date
- 2022-10-07
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 88
- Registration Number
- NCT04474886
- Locations
- 🇭🇰
The Chinese University of Hong Kong, Hong Kong, Hong Kong
Long-term Follow-up of Children With OSA Treated With AT
Recruiting
- Conditions
- Obstructive Sleep Apnea
- Interventions
- Procedure: Adenotonsillectomoy +/- turbinate reduction
- First Posted Date
- 2020-07-16
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 180
- Registration Number
- NCT04473066
- Locations
- 🇭🇰
Department of Paediatrics, The Chinese University of Hong Kong, Sha Tin, Hong Kong
🇭🇰Department of Paediatrics, Kwong Wah Hospital, Hong Kong, Kowloon, Hong Kong
Primary Percutaneous Pericardiotomy for Malignant Pericardial Effusion (PMAP)
Not Applicable
Terminated
- Conditions
- Pericardial Effusion Malignant
- Interventions
- Device: Percutaneous Balloon Pericardiotomy
- First Posted Date
- 2020-07-15
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 50
- Registration Number
- NCT04472468
- Locations
- 🇭🇰
Prince of Wales Hospital, Hong Kong, Shatin, Hong Kong
Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)
Recruiting
- Conditions
- COVID-19
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 3000
- Registration Number
- NCT04465474
- Locations
- 🇪🇸
Hospital Universitario de Torrejón, Torrejón De Ardoz, Madrid, Spain
🇭🇰Princess Margaret Hospital, Hong Kong, Hong Kong
🇭🇰Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong
An Observational Study on Patients With NTM Pulmonary Disease
- Conditions
- Clinical Outcomes
- Interventions
- Drug: NTM drug treatment
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2020-07-14
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 50
- Registration Number
- NCT04463134
A Novel Ballet-inspired Low-impact At-home Workout Programme for Adults with Stroke
Not Applicable
Completed
- Conditions
- Memory ImpairmentGait, UnsteadyBalance; DistortedStroke
- Interventions
- Other: Usual careBehavioral: Ballet-inspired workouts
- First Posted Date
- 2020-07-08
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 32
- Registration Number
- NCT04460794
- Locations
- 🇭🇰
Alice Ho Miu Ling Nethersole Hospital, Hong Kong, Hong Kong
Manuka Honey Eye Drops VS Conventional Treatment of Meibomian Gland Dysfunction Related Dry Eye Disease
Phase 4
Completed
- Conditions
- Meibomian Gland Dysfunction
- Interventions
- Device: manuka honey 16% eye drops ( Optimel )Device: systane eye drops
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2020-07-07
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 59
- Registration Number
- NCT04457648
- Locations
- 🇨🇳
chinese university of Hong kong, Hong Kong, China
HFNC and NIV for COVID-19 Complicated by Respiratory Failure
Completed
- Conditions
- Respiratory Failure
- Interventions
- Device: HFNC
- First Posted Date
- 2020-06-30
- Last Posted Date
- 2022-07-25
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 26
- Registration Number
- NCT04452708
- Locations
- 🇭🇰
Prince of Wales Hospital, Hong Kong, Hong Kong
© Copyright 2025. All Rights Reserved by MedPath